|
Pulmonary circulation and disease
Citations 1-10 of 333 total displayed.
|
Most recent content
(25 Aug 2008):
|
- Articles
Fhl-1, a New Key Protein in Pulmonary Hypertension
- Grazyna Kwapiszewska, Malgorzata Wygrecka, Leigh M. Marsh, Sigrid Schmitt, Roger Trösser, Jochen Wilhelm, Katja Helmus, Bastian Eul, Anna Zakrzewicz, Hossein A. Ghofrani, Ralph T. Schermuly, Rainer M. Bohle, Friedrich Grimminger, Werner Seeger, Oliver Eickelberg, Ludger Fink, and Norbert Weissmann
Circulation published August 25, 2008, doi:10.1161/CIRCULATIONAHA.107.761916
[Abstract]
|
Past content
(since Feb 1999):
|
- Molecular Cardiology
Genetic Ablation of the Bmpr2 Gene in Pulmonary Endothelium Is Sufficient to Predispose to Pulmonary Arterial Hypertension
- Kwon-Ho Hong, Young Jae Lee, Eunji Lee, Sung Ok Park, Chul Han, Hideyuki Beppu, En Li, Mohan K. Raizada, Kenneth D. Bloch, and S. Paul Oh
Circulation 118: 722 -730; published online before print as doi:10.1161/CIRCULATIONAHA.107.736801
[Abstract]
[Full text]
- Articles
Genetic Ablation of the Bmpr2 Gene in Pulmonary Endothelium Is Sufficient to Predispose to Pulmonary Arterial Hypertension
- Kwon-Ho Hong, Young Jae Lee, Eunji Lee, Sung Ok Park, Chul Han, Hideyuki Beppu, En Li, Mohan K. Raizada, Kenneth D. Bloch, and S. Paul Oh
Circulation published July 28, 2008, doi:10.1161/CIRCULATIONAHA.107.736801
[Abstract]
- Editorials
The Status of Pulmonary Arterial Hypertension in 2008
- Harrison W. Farber
Circulation 2008; 117: 2966-2968, doi:10.1161/CIRCULATIONAHA.108.782979
[Full text]
- Vascular Medicine
Ambrisentan for the Treatment of Pulmonary Arterial Hypertension: Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2
- Nazzareno Galiè, Horst Olschewski, Ronald J. Oudiz, Fernando Torres, Adaani Frost, Hossein A. Ghofrani, David B. Badesch, Michael D. McGoon, Vallerie V. McLaughlin, Ellen B. Roecker, Michael J. Gerber, Christopher Dufton, Brian L. Wiens, Lewis J. Rubin for the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy Studies (ARIES) Group
Circulation 117: 3010 -3019; published online before print as doi:10.1161/CIRCULATIONAHA.107.742510
[Abstract]
[Full text]
- Vascular Medicine
Circulating Endothelial Progenitor Cells in Patients With Eisenmenger Syndrome and Idiopathic Pulmonary Arterial Hypertension
- Gerhard-Paul Diller, Sven van Eijl, Darlington O. Okonko, Luke S. Howard, Omar Ali, Thomas Thum, Stephen J. Wort, Elisabeth Bédard, J. Simon R. Gibbs, Johann Bauersachs, Adrian J. Hobbs, Martin R. Wilkins, Michael A. Gatzoulis, and John Wharton
Circulation 117: 3020 -3030; published online before print as doi:10.1161/CIRCULATIONAHA.108.769646
[Abstract]
[Full text]
- Vascular Medicine
Converging Evidence in Support of the Serotonin Hypothesis of Dexfenfluramine-Induced Pulmonary Hypertension With Novel Transgenic Mice
- Yvonne Dempsie, Ian Morecroft, David J. Welsh, Neil A. MacRitchie, Nigel Herold, Lynn Loughlin, Margaret Nilsen, Andrew J. Peacock, Anthony Harmar, Michael Bader, and Margaret R. MacLean
Circulation 117: 2928 -2937; published online before print as doi:10.1161/CIRCULATIONAHA.108.767558
[Abstract]
[Full text]
- Articles
Circulating Endothelial Progenitor Cells in Patients With Eisenmenger Syndrome and Idiopathic Pulmonary Arterial Hypertension
- Gerhard-Paul Diller, Sven van Eijl, Darlington O. Okonko, Luke S. Howard, Omar Ali, Thomas Thum, Stephen J. Wort, Elisabeth Bédard, J. Simon R. Gibbs, Johann Bauersachs, Adrian J. Hobbs, Martin R. Wilkins, Michael A. Gatzoulis, and John Wharton
Circulation published June 2, 2008, doi:10.1161/CIRCULATIONAHA.108.769646
[Abstract]
- Articles
Converging Evidence in Support of the Serotonin Hypothesis of Dexfenfluramine-Induced Pulmonary Hypertension With Novel Transgenic Mice
- Yvonne Dempsie, Ian Morecroft, David J. Welsh, Neil A. MacRitchie, Nigel Herold, Lynn Loughlin, Margaret Nilsen, Andrew J. Peacock, Anthony Harmar, Michael Bader, and Margaret R. MacLean
Circulation published May 27, 2008, doi:10.1161/CIRCULATIONAHA.108.767558
[Abstract]
- Articles
Ambrisentan for the Treatment of Pulmonary Arterial Hypertension. Results of the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy (ARIES) Study 1 and 2
- Nazzareno Galiè, Horst Olschewski, Ronald J. Oudiz, Fernando Torres, Adaani Frost, Hossein A. Ghofrani, David B. Badesch, Michael D. McGoon, Vallerie V. McLaughlin, Ellen B. Roecker, Michael J. Gerber, Christopher Dufton, Brian L. Wiens, Lewis J. Rubin for the Ambrisentan in Pulmonary Arterial Hypertension, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Efficacy Studies (ARIES) Group
Circulation published May 27, 2008, doi:10.1161/CIRCULATIONAHA.107.742510
[Abstract]
|
|
